scholarly journals Complicated urinary tract infection in patients with benign prostatic hyperplasia

Author(s):  
Jin Bong Choi ◽  
Seung Ki Min
2005 ◽  
Vol 3 (4) ◽  
pp. 0-0
Author(s):  
Audrius Rimas ◽  
Balys Dainys

Audrius Rimas, Balys DainysVilniaus universiteto ligoninės Santariškių klinikosNefrologijos ir urologijos centras,Santariškių g. 2, LT-08661 VilniusEl paštas: [email protected], [email protected] Tikslas Apibendrinti ir įvertinti nepiktybinės prostatos hiperplazijos gydymo rezultatus, naudojant transuretrinę mikrobangų termoterapiją. Ligoniai ir metodai Retrospektyviai išanalizuoti 99 pacientų termoterapijos rezultatai. Gydytų vyrų amžiaus vidurkis – 71,9 metų. Ligoniai šiam gydymui atrinkti atsižvelgus į skundus, maksimalų šlapimo srovės greitį, transrektalinę prostatos echoskopiją ir liekamąjį šlapimą. Viršgaktiniu šlapimo pūslės drenažu gydytas 31 vyras. Šlapimo takų infekcija nustatyta 22 ligoniams prieš gydymą. Termoterapijai naudotas firmos "Dornier" aparatas "UroWave". Rezultatai Pagal Tarptautinę prostatos simptomų skalę skundai sumažėjo nuo 11,2 iki 7 balų (62,5%), prostatos tūris – nuo 70 ml iki 60 ml (15,7%), maksimalus srovės greitis padidėjo nuo 8 ml/s iki 15 ml/s (53,3%), liekamojo šlapimo kiekis liko nereikšmingas, pašalintos cistostomos 22 ligoniams iš 31 (70,1%), po 24 mėn. 7 ligoniai operuoti, 10 ligonių atlikta pakartotinė termoterapija, medikamentinis gydymas skirtas 20 ligonių. Pasiteikė šios komplikacijos: hematurija – 23 (23,3%) ligoniams; kraujavimas – vienam (1,01%); ūminis šlapimo susilaikymas – aštuoniems (8,08%); šlapimo takų infekcijos paūmėjimas – vienam (1,01%). Išvados Mikrobangų termoterapija yra veiksmingas ir saugus nepiktybinės prostatos hiperplazijos gydymo būdas. Simptominis ir urodinaminis pagerėjimas po termoterapijos išliko iki 24 mėnesių. Geriausias poveikis gautas 3–18 mėnesiais. Pavojingų sveikatai ir gyvybei komplikacijų po mikrobangų termoterapijos nepasitaikė. Šlapimo takų infekcija blogina termoterapijos rezultatą ankstyvuoju laikotarpiu, vėliau ligos baigčiai ji reikšmės neturi. Reikšminiai žodžiai: nepiktybinė prostatos hiperplazija, transuretrinė mikrobangų termoterapija, hipertermija Early and follow-up clinical results of transurethral microwave thermotherapy for benign prostatic hyperplasia Audrius Rimas, Balys DainysVilnius University Hospital "Santariškių klinikos",Center of Nephrology and Urology,Santariškių str. 2,LT-08661 Vilnius, LithuaniaE-mail: [email protected], [email protected] Objective To evaluate the results of transurethral microwave thermotherapy for benign prostatic hyperplasia. Patients and methods The results of thermotherapy were analysed retrospectively for 99 cases of prostatic hyperplasia. The mean age of patients was 71.9 years. Initial evaluation consisted of a history, peak urinary flow rate, transrectal prostate ultrasonography and post-voiding urinary volume. Suprapubic urinary drainage was done in 31 cases. Urinary tract pre-infection was found in 22 patients. We used a UroWave (Dornier) device for thermotherapy. Results The complaints according to IPSS decreased from 11.2 to 7 (62.5%), the prostate volume from 70 to 60 ml (15.7%), the peak flow rate increased from 8 to 15 ml/s (53.3%), residual urinary volume was insignificant after treatment, cistostoms were removed in 22 cases from 31 (70.1%), after 24 months 7 patients were operated on, 10 patients underwent retreatment with thermotherapy, medication was administered in 20 cases. We noticed the following complications: hematuria in 23 (23.3%) patients, bleeding 1 (1.01%), acute retention of urination 8 (8.08%), exacerbation of urinary tract infection 1 (1.01%). Conclusions Microwave thermotherapy is an efficacious and safe method of treatment of benign prostatic hyperplasia. Symptomatic and urodynamic improvement after thermotherapy persisted for 24 months. The best results were obtained 3–18 months after treatment. We found no high-risk complications after thermotherapy. Urinary tract infection worsened the results of microwave thermotherapy only in the early post-treatment period. Keywords: benign prostatic hyperplasia, transurethral microwave thermotherapy, hyperthermia, minimally invasive therapy


2021 ◽  
Author(s):  
Zelalem Asefa

Abstract Background: Benign prostatic hyperplasia (BPH) is the commonest cause of bladder outlet obstruction (BOO) in elderly males. It is characterised by lower urinary tract symptoms (LUTS) that include voiding/obstructive and storage/irritative symptoms. If untreated, patients could suffer from different associated complications such as hydronephrosis, urinary tract infection and even renal failure. Little is known about the magnitude and pattern of associated complications of BOO secondary to BPH.Objectives: To assess the clinical profile, magnitude and pattern of associated complications of BOO among patients with BPH at Yekatit 12 hospital, Addis Ababa, Ethiopia.Methods: A retrospective crossectional hospital based analysis of 225 patients who underwent prostatectomy for BOO secondary to BPH over a five year period, from January 1, 2015 to December 31, 2019 was done. Data were analysed using SPSS version 20. Results: Frequency of micturition, dysuria and nocturia were the commonest presenting symptoms observed in 94.2%, 89.3% and 84.9% of the patients, respectively. One hundred and thirty (57.8%) patients presented to the hospital 2 years after the onset of their symptoms. History of prehospital antibiotic treatment for recurrent urinary tract infection (UTI) was found in 64.4% of the patients. Associated complications of BOO secondary to BPH were observed in 44% of the patients. Acute urinary retention (AUR) and urinary tract infection (UTI) were the commonest associated complications observed in 50.7% and 30.7% of the patients, respectively. Hydronephrosis (21.8%), renal impairment (19.1%), urinary tract stones (13.3%) and frank haematuria (4.4%) were other complications observed in this series. Conclusion: Storage/irritative LUTS predominate among our patients with BPH. Associated complications of BOO secondary to BPH were prevalent in the study. Acute urinary retention (AUR) and urinary tract infection (UTI) were the commonest associated complications observed. In order to avoid late diagnosis and reduce the occurrence of possible complications, clinicians should be aware of the possibility of BPH even if the storage/ irritative symptoms predominate in elderly males.


2020 ◽  
Vol 36 ◽  
Author(s):  
Musliu Adetola Tolani ◽  
Aisha Suleiman ◽  
Mudi Awaisu ◽  
Muhammad Mukhtar Abdulaziz ◽  
Ahmad Tijjani Lawal ◽  
...  

2015 ◽  
Vol 2015 ◽  
pp. 1-2 ◽  
Author(s):  
Asad Jehangir ◽  
Dilli Poudel ◽  
Shoaib Bilal Fareedy ◽  
Ahmed Salman ◽  
Anam Qureshi ◽  
...  

A 62-year-old male with past medical history of benign prostatic hyperplasia presented to the emergency department with complaints of decreased urinary flow, inability to fully empty his bladder, and gross hematuria. Physical examination was unremarkable. Urinalysis revealed large amount of blood and more than 700 white blood cells suggesting a urinary tract infection. Urine culture grew group DSalmonellagreater than 100,000 colony-forming units per mL. He was prescribed 6 weeks of trimethoprim/sulfamethoxazole and had resolution of symptoms. Retrospectively, he reported a 3-day history of watery diarrhea about a week prior to onset of urinary symptoms that was presumed to be the hematogenous source in this case. Urinary tract infection from nontyphoidalSalmonella(NTS) is rare and is usually associated with immunosuppression, chronic diseases, such as diabetes or structural abnormalities of the genitourinary tract. Genitourinary tract abnormalities previously reported in the literature that predispose to nontyphoidalSalmonellaurinary tract infection include nephrolithiasis, chronic pyelonephritis, retrovesicular fistula, urethrorectal fistula, hydrocele, and post-TURP. We present an exceedingly uncommon case of 62-year-old male with group DSalmonellaurinary tract infection predisposed by his history of benign prostatic hyperplasia.


2021 ◽  
Vol 11 (1) ◽  
Author(s):  
Tanya Babich ◽  
Noa Eliakim-Raz ◽  
Adi Turjeman ◽  
Miquel Pujol ◽  
Jordi Carratalà ◽  
...  

AbstractHospital readmissions following severe infections are a major economic burden on the health care system and have a negative influence on patients' quality of life. Understanding the risk factors for readmission, particularly the extent to which they could be prevented, is of a great importance. In this study we evaluated potentially preventable risk factors for 60-day readmission in patients surviving hospitalization for complicated urinary tract infection (cUTI). This was a multinational, multicentre retrospective cohort study conducted in Europe and the Middle East. Our cohort included survivors of hospitalization due to cUTI during the years 2013–2014. The primary outcome was 60-day readmission following index hospitalization. Patient characteristics that could have influenced readmission: demographics, infection presentation and management, microbiological and clinical data; were collected via computerized medical records from infection onset up to 60 days after hospital discharge. Overall, 742 patients were included. The cohort median age was 68 years (interquartile range, (IQR) 55–80) and 43.3% (321/742) of patients were males. The all-cause 60-day readmission rate was 20.1% (149/742) and more than half were readmitted for infection [57.1%, (80/140)]. Recurrent cUTI was the most frequent cause for readmission [46.4% (65/140)]. Statistically significant risk factors associated with 60-day readmission in multivariable analysis were: older age (odds ratio (OR) 1.02 for an one-year increment, confidence interval (CI) 1.005–1.03), diabetes mellitus (OR 1.63, 95% CI 1.04–2.55), cancer (OR 1.7, 95% CI 1.05–2.77), previous urinary tract infection (UTI) in the last year (OR 1.8, 95% CI: 1.14–2.83), insertion of an indwelling bladder catheter (OR 1.62, 95% CI 1.07–2.45) and insertion of percutaneous nephrostomy (OR 3.68, 95% CI 1.67–8.13). In conclusion, patients surviving hospitalization for cUTI are frequently re-hospitalized, mostly for recurrent urinary infections associated with a medical condition that necessitated urinary interventions. Interventions to avoid re-admissions should target these patients.


Sign in / Sign up

Export Citation Format

Share Document